Our mission is to make cancer visible during surgery so it can be removed more completely.

On Target Laboratories’ fluorescence imaging technology is being developed to illuminate cancer during surgery, potentially enabling surgeons to see and remove more diseased tissue.

ON TARGET technology has the potential to give skilled surgeons added intraoperative visibility which may increase the likelihood of a more complete resection. ON TARGET technology has the potential to give skilled surgeons added intraoperative visibility which may increase the likelihood of a more complete resection.

Surgeons step into the OR with a variety of pre-operative inputs that help locate tumors and suspicious lesions — but finding small lesions can still be challenging.

By targeting and illuminating cancerous tissue during a procedure, On Target’s technology has the potential to give skilled surgeons the added benefit of intraoperative sight. This added visibility may increase the likelihood of a more complete surgical resection. Complete resections are associated with reduced re-operations or adjuvant treatments1, and for patients could translate into improved outcomes.

On Target’s technology gives surgeons intraoperative visibility of cancerous tissue, potentially increasing the chance for a complete surgical resection.

Read the Science

 

1. Riquet, Mark, et al. Microscopic Residual Disease After Resection for Lung Cancer: A Multifaceted but Poor Factor of Prognosis. Ann Thorac Surg. 2010;89: 870-6. doi:10.1016/j.athoracsur.2009.12.037.

Brand Strategy By Assembly
Developed By Alchemy + Aim